Business News distributed by GlobeNewswire
Category:
GlobeNewswire
-
MILAN, Nov. 20, 2024 (GLOBE NEWSWIRE) — With today’s distribution of €3 billion in interim …
-
Ben Austin, CFO and COO of SPR® Therapeutics, Named to Crain’s Cleveland Business 40 Under 40 List
by Asia InsiderBen Austin, SPR Therapeutics Ben Austin, Chief Financial Officer and Chief Operating Officer of SPR …
-
Soft Play Celebrates 40 Years of Pioneering Indoor Playground Equipment With Six-Story Thanksgiving Point Installation, Its Largest Project Ever
by Asia InsiderHUNTERSVILLE, N.C., Nov. 18, 2024 (GLOBE NEWSWIRE) — Soft Play, a global leader in contained …
-
Reduces diagnostic turnaround times from a week to just one day RIYADH, Saudi Arabia, Nov. …
-
ROSEN, A GLOBALLY RESPECTED INVESTOR RIGHTS FIRM, Encourages Lilium N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LILM, LILMF
by Asia InsiderNEW YORK, Nov. 17, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor …
-
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IPXX, YOTA, ALVR on Behalf of Shareholders
by Asia InsiderNEW YORK, Nov. 16, 2024 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law …
-
Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression in Transthyretin (ATTR) Amyloidosis
by Asia InsiderConsistently rapid, deep and durable reduction in serum TTR accompanied by evidence of disease stabilization …
-
THAMES VENTURES VCT 2 PLC LEI: 21380035MV1VRYEXPR95 GENERAL MEETING AND MERGER RESULTS15 NOVEMBER 2024 Introduction …
-
Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion
by Asia InsiderEight participants achieved HBsAg loss at any time.Two participants met criteria for functional cure. Two …